Back
MAX S&P 500 4X Leveraged ETN Vs. Viking Therapeutics Industry Stock Comparison
Sell
29
SPYU
MAX S&P 500 4X Leveraged ETN
Last Price:
43.87
Seasonality Move:
--
Sell
45
VKTX
Viking Therapeutics
Last Price:
63.15
Seasonality Move:
38.04%
Sell
29
MAX S&P 500 4X Leveraged ETN (SPYU)
is a Sell
Is MAX S&P 500 4X Leveraged ETN a Buy, Sell or Hold?
- The current MAX S&P 500 4X Leveraged ETN [SPYU] share price is $43.93. The Score for SPYU is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SPYU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPYU Stock Price Chart
What is MAX S&P 500 4X Leveraged ETN's stock price today?
-
The MAX S&P 500 4X Leveraged ETN share price today is $43.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPYU is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
SPYU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | -152848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.2 - 48.76) | Sell |
| Bollinger Bands (100): | (39.97 - 47.11) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.92 | Buy |
| Relative Strength Index (14 RSI): | 44.37 | Sell |
| Chaikin Money Flow: | -27799915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.04 - 71.46) | Sell |
| Bollinger Bands (100): | (52.9 - 66.58) | Buy |
SPYU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.26 | Sell |
| 20-day SMA: | 47.44 | Sell |
| 50-day SMA: | 45.1 | Sell |
| 200-day SMA: | 39.57 | Buy |
| 8-day EMA: | 45.8 | Sell |
| 20-day EMA: | 46.5 | Sell |
| 50-day EMA: | 45.35 | Sell |
| 200-day EMA: | 11.11 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.43 | Sell |
| 20-day SMA: | 67.48 | Sell |
| 50-day SMA: | 64.43 | Sell |
| 200-day SMA: | 59.82 | Buy |
| 8-day EMA: | 69.69 | Sell |
| 20-day EMA: | 68.14 | Sell |
| 50-day EMA: | 65.07 | Sell |
| 200-day EMA: | 55.33 | Buy |
MAX S&P 500 4X Leveraged ETN Earnings Growth & SPYU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
MAX S&P 500 4X Leveraged ETN Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||